AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

177.560

+3.1501.81%

Volume:1.98M

Turnover:349.94M

Market Cap:85.04B

PE:-23.61

High:177.970

Open:175.000

Low:174.000

Close:174.410

52wk High:216.734

52wk Low:88.830

Shares:478.91M

Float Shares:478.91M

Volume Ratio:1.71

T/O Rate:0.41%

Dividend:4.10

Dividend Rate:2.31%

EPS(TTM):-7.520

EPS(LYR):-7.520

ROE:-15.83%

ROA:7.26%

PB:4.09

PE(LYR):-23.61

Loading ...

Overview Company News Filings

Does CSL (ASX:CSL) Losing TAVNEOS Authorisation Undermine Its Diversification And Regulatory Resilience Story?

Simply Wall St.

Commonwealth Bank Stock And 2 Australian Dividend Shares For Reliable Income

Simply Wall St.

Australian Healthcare Stocks at Two-month High, CSL Rises over 3%

Is CSL (ASX:CSL) Cheap On Tavneos Revocation Risk?

Simply Wall St.

3 Dividend Growth Stocks Riding Grid And Industrial Spending Trends

Simply Wall St.

Commonwealth Bank Stock And 2 Australian Dividend Shares Worth A Closer Look

Simply Wall St.

Csl's Latest Blow Supports Continued Caution

Market Chatter: Carlisle Companies Made Unsolicited Offers for Owens Corning

MT Newswires Live

CSL to Cease New Patient Initiation for Tavneos in EU and Eea Markets

CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe

MT Newswires Live

To Provide Details on Tavneos Ip Impairment in 2026 Full Year Results

THOMSON REUTERS

Expects FY26 Tavneos Sales Revenue of About $145 Mln

THOMSON REUTERS

To Cease New Patient Initiation for Tavneos in EU and Eea Markets

THOMSON REUTERS

Ema Chmp Recommends Revocation of EU Marketing Authorisation for Tavneos on Jun 26

THOMSON REUTERS

Commonwealth Bank Stock And 2 ASX Dividend Shares Paying More Than 3%

Simply Wall St.

Chmp Recommends Revoking Marketing Authorisation for Tavneos® (avacopan) in the European Union

THOMSON REUTERS

EU Commission Opens Antitrust Probe into Sanofi's Flu Vaccine Campaign

Sanofi Spokesperson on EU Probe: Cooperating Fully with the European Commission Throughout the Process

THOMSON REUTERS

Sanofi Spokesperson on EU Probe: Sanofi is Confident That it Has Acted, and Continues to Act, in Full Compliance with All Applicable Laws and Regulations

THOMSON REUTERS

Commonwealth Bank Stock And 2 Australian Dividend Shares For Steady Income

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/CSL.AU/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":177.56,"timestamp":1789625520000,"preClose":174.41,"halted":0,"volume":1984012,"delay":0,"changeRate":0.018060891003956227,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.521238712870033,"marketStatus":"Not Yet Opened","change":3.15,"latestTime":"09-17 16:12:00 AEST","open":175,"high":177.97,"low":174,"amount":349936229,"amplitude":0.022762,"askPrice":177.65,"askSize":166,"bidPrice":176,"bidSize":74,"shortable":3,"etf":0,"ttmEps":-7.521238712870033,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":174.41,"dividendRate":0.022949,"openAndCloseTimeList":[[1789603200000,1789624800000]],"volumeRatio":1.708257,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":174.41,"auctionPrice":177.56,"auctionVolume":388155,"auction":3,"marketStatus":"盘后竞价","timestamp":1789625422961}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.519526,"volumeRatio":1.708257,"shares":478911979,"dividePrice":4.104115,"high":177.97,"amplitude":0.022762,"preClose":174.41,"low":174,"week52Low":88.83,"pbRate":"4.09","psRate":"3.83","week52High":216.734,"institutionHeld":0,"latestPrice":177.56,"committee":-0.383333,"eps":-7.519526171464873,"divideRate":0.023114,"volume":1984012,"delay":0,"ttmEps":-7.519526171464873,"open":175,"prevYearClose":168.21,"prevWeekClose":167.1,"prevMonthClose":169.351,"prevQuarterClose":113.256,"fiveDayClose":169.5,"twentyDayClose":168.986,"sixtyDayClose":116.128,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.01866467227077263},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2649691995","title":"Does CSL (ASX:CSL) Losing TAVNEOS Authorisation Undermine Its Diversification And Regulatory Resilience Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649691995","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649691995?lang=en_us&edition=fundamental","pubTime":"2026-07-04 22:25","pubTimestamp":1783175140,"startTime":"0","endTime":"0","summary":"The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended revoking CSL Vifor’s TAVNEOS marketing authorisation in the EU, after finding manipulated and unreliable pivotal trial data and prompting CSL to halt new patient starts across EMA jurisdictions.\nThis setback not only raises the prospect of an impairment charge for TAVNEOS intellectual property, but also highlights how regulatory scrutiny can directly test CSL’s diversification benefits and risk...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-losing-tavneos-authorisation-undermine-its-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-losing-tavneos-authorisation-undermine-its-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","SGXZ23171101.USD","LU1169590202.USD","BK4086","BK7067","CSL.AU","BK7508","CSL","LU0728928796.USD","BK7511","SG9999004303.SGD","LU1169589451.USD","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648165489","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares For Reliable Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2648165489","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648165489?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:36","pubTimestamp":1783060582,"startTime":"0","endTime":"0","summary":"In a world where inflation signals, interest rate expectations and growth data keep shifting, many investors are looking for income that feels more reliable than the latest macro headline. That is where Dividend Powerhouses with yields above 5% and well covered, growing payouts can help. This screener focuses on companies that have kept dividends both stable and on an upward path, which can be appealing when bond yields, labor data and central bank messages keep moving around. In this...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BEAR.AU","AGIX","STW.AU","NST.AU","US2Y.BOND","XJO.AU","TLT","DACE.AU","TLTW","CSL.AU","QFN.AU","ZYAU.AU","BBOZ.AU","US10Y.BOND","US7Y.BOND","BK7104","BK7501","AIPO","IISV.AU","CBA.AU","GEAR.AU","EIGA.AU","OZF.AU","US6M.BOND","XKO.AU","QRE.AU","US5Y.BOND","TMF","OZR.AU","BK7506","US30Y.BOND","US3Y.BOND","BK7508","VAP.AU","SLF.AU","VAS.AU","IMLC.AU","IIGF.AU","E200.AU","BK7135","IOZ.AU","US12M.BOND","GIVE.AU","BK7067","ARTY","XAO.AU","CHAT","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648665536","title":"Australian Healthcare Stocks at Two-month High, CSL Rises over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648665536","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648665536?lang=en_us&edition=fundamental","pubTime":"2026-07-03 13:48","pubTimestamp":1783057739,"startTime":"0","endTime":"0","summary":"BUZZ-Australian healthcare stocks at two-month high, CSL rises over 3%** Australian health stocks.AXHJrise as much as 2.7%, their highest level since April 22** Stocks gain more than 5% so far this week, their best level since early-November, 2022** Extends gains for a seventh consecutive week** \"Healthcare was battered in the last FY, and has been stabilising in the last couple of months, and investors are finally waking up to how cheap they are in a historical context,\" says Mark Gardner, founder and chief executive officer at MPC Markets** Shares of CSLCSL.AXand CochlearCOH.AXgain over 3% each** Sub-index down ~20% YTD, including the session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nL6N4350AF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7511","COH.AU","CSL.AU","BK7067","BK7007","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648021795","title":"Is CSL (ASX:CSL) Cheap On Tavneos Revocation Risk?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648021795","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648021795?lang=en_us&edition=fundamental","pubTime":"2026-07-02 16:46","pubTimestamp":1782981994,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is back in focus after the European Medicines Agency’s committee recommended revoking the EU marketing authorisation for Tavneos. This has raised fresh questions about the CSL Vifor unit and the stock’s recent recovery.\nSee our latest analysis for CSL.\nThe Tavneos setback arrives after a sharp 27.21% 1 month share price return for CSL. However, this sits against a weaker backdrop, with the stock down 31.52% year to date and the 1 year total shareholder return declining 49.94%,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-tavneos-revocation-risk","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/is-csl-asxcsl-cheap-on-tavneos-revocation-risk","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SGXZ23171101.USD","BK7508","SG9999004303.SGD","BK7511","BK7501","BK4086","CSL.AU","CSL","LU0728928796.USD","BK7067","LU1169589451.USD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593119","title":"3 Dividend Growth Stocks Riding Grid And Industrial Spending Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593119","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593119?lang=en_us&edition=fundamental","pubTime":"2026-07-01 07:20","pubTimestamp":1782861615,"startTime":"0","endTime":"0","summary":"Dividend growth stocks sit at an interesting crossroads for income investors who want more than just a static payout. When a company steadily lifts its dividend, it can signal confidence in its cash generation and a willingness to share that cash with shareholders. This article looks at how one recent news event may affect a select group of dividend growers, and what that could mean for your watchlist. Ahead, you will find three stocks from our Dividend Growth Stocks screener that appear...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3081000-choice2-main-header/1585186749644"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/news/3-dividend-growth-stocks-riding-grid-and-industrial-spending","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-fast/fastenal/news/3-dividend-growth-stocks-riding-grid-and-industrial-spending","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2357125470.USD","BK4585","BK4104","BK4533","CSL","IE0034235188.USD","LU2264538146.SGD","BK4086","IE00BFXG0V08.USD","IE00B3CCJ633.GBP","IE00BZ199S13.USD","LU2506951792.HKD","LU1074936037.SGD","LU1815333072.USD","LU1861214812.USD","LU0823414551.USD","IE00BZ1G4Q59.USD","CSL.AU","BK7501","LU1169589451.USD","BK4543","BK4567","IE00B2PGVK34.USD","LU0957791311.USD","BK7067","LU2294711713.HKD","IE00B19Z8W00.USD","BK4096","IE0004445239.USD","LU1861219969.SGD","LU0096362180.USD","LU2360107325.USD","IE00B19Z9505.USD","LU1989764664.SGD","BK4588","LU2249611893.SGD","IE00BD6J9T35.USD","LU1169590202.USD","BK7511","LU1064131342.USD","IE00B5TLWC47.USD","FAST","LU1988902786.USD","IE00BYQQ9H92.USD","BK7508","LU0061474960.USD","SGXZ23171101.USD","ETN","IE00BGHQF417.EUR","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647814495","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares Worth A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2647814495","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647814495?lang=en_us&edition=fundamental","pubTime":"2026-06-30 10:13","pubTimestamp":1782785612,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses can appeal when inflation, interest rates and consumer confidence are all in flux, as they are today. With policy paths diverging across the US, Europe and Asia, many investors are looking for income streams that are both sizeable and supported by stable cash flows. The Dividend Powerhouses (3%+ Yield) screener focuses on companies that pay a higher yield, with dividends that are covered and have a record of stability. This article highlights 3 stocks from that screener,...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-wor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-wor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK4535","IIGF.AU","GBUG","SLF.AU","E200.AU","XJO.AU","QRE.AU","VAP.AU","BEGS","GIVE.AU","VIG","XKO.AU","XME","EIGA.AU","CSL.AU","DACE.AU","GOAU","BBOZ.AU","QFN.AU","UYM","CBA.AU","BK7135","BK7508","BK7506","CEF","BK7511","BEAR.AU","VAS.AU","BK7501","BK7104","IOZ.AU","IISV.AU","GLTR","OZR.AU","GEAR.AU","IMLC.AU","ZYAU.AU","STW.AU","OZF.AU","XAO.AU","BK4588","PICK","EVN.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588908","title":"Csl's Latest Blow Supports Continued Caution","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588908","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647588908?lang=en_us&edition=fundamental","pubTime":"2026-06-30 07:56","pubTimestamp":1782777360,"startTime":"0","endTime":"0","summary":"2356 GMT - The almost certain withdrawal of the CSL-marketed Tavneos therapy in Europe only adds to Macquarie's caution toward the Australian biotechnology company. An analyst at the investment bank tells clients in a note that a European Commission ruling on the treatment appears to be a formality, and trims EPS forecasts by 3% for fiscal 2027 and by 4% for fiscal 2028. The analyst reiterates a neutral rating on the stock and reminds readers of the significant near-term earnings uncertainty across CSL's core business segments, plus ongoing medium-term competitive risks. Target price rises 2.7% to 114.00 Australian dollars, reflecting currency moves. Shares are at A$115.39 ahead of the open.  Dow Jones NewswiresJune 29, 2026 19:56 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7508","BK7067","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647459306","title":"Market Chatter: Carlisle Companies Made Unsolicited Offers for Owens Corning","url":"https://stock-news.laohu8.com/highlight/detail?id=2647459306","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647459306?lang=en_us&edition=fundamental","pubTime":"2026-06-30 01:24","pubTimestamp":1782753884,"startTime":"0","endTime":"0","summary":"Carlisle Companies  has made multiple unsolicited offers to acquire Owens Corning , with a potential deal valued at over $10 billion, The Wall Street Journal reported Monday, citing people familiar with the matter.Owens Corning has not yet engaged substantially with Carlisle, the report said, adding that Carlisle is now evaluating its next move.Carlisle Companies, Owens Corning did not immediately respond to MT Newswires' request for comment.Price: 369.68, Change: -18.70, Percent Change: -4.81","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B3CCJ633.GBP","LU0868494617.USD","IE00BFMHRM44.USD","GLW","LU1720051017.SGD","SGXZ23171101.USD","LU2473716301.USD","LU2092937221.SGD","BK7067","LU0728928796.USD","LU2322448791.USD","LU2048586759.USD","LU2543165471.USD","BK4086","LU2272731865.HKD","BK4148","LU2023250843.SGD","IE00B2PGVK34.USD","BK7511","OC","CSL.AU","LU2023250504.SGD","LU2272731782.SGD","LU2357305700.SGD","LU2298321311.HKD","SG9999004303.SGD","IE00BGHQF417.EUR","LU1169590202.USD","LU2041044095.USD","BK7508","BK4588","LU1917777945.USD","LU1974910355.USD","GLWG","LU1169589451.USD","LU2272731600.USD","LU2360108059.USD","CSL","BK4512","BK4585","LU1548497426.USD","LU2322448957.HKD","BK7501","LU1992135399.USD","LU1992135472.HKD","CNAV","LU1720051108.HKD","LU2106854487.HKD","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647344990","title":"CSL to Cease New Patient Initiation for Tavneos in EU and Eea Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2647344990","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647344990?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:27","pubTimestamp":1782696438,"startTime":"0","endTime":"0","summary":"BRIEF-CSL To Cease New Patient Initiation For Tavneos In EU And Eea MarketsJune 29 -CSL LtdCSL.AX:TO CEASE NEW PATIENT INITIATION FOR TAVNEOS IN EU AND EEA MARKETSEMA CHMP RECOMMENDS REVOCATION OF EU MARKETING AUTHORISATION FOR TAVNEOS ON JUN 26TO PROVIDE DETAILS ON TAVNEOS IP IMPAIRMENT IN 2026 FULL YEAR RESULTSEXPECTS FY26 TAVNEOS SALES REVENUE OF ABOUT $145 MILLIONFurther company coverage:CSL.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN42Y121:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK7501","BK7511","CSL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647334151","title":"CSL Says CHMP Recommends Revocation of TAVNEOS Marketing Authorization in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2647334151","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647334151?lang=en_us&edition=fundamental","pubTime":"2026-06-29 08:22","pubTimestamp":1782692567,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) said the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued an opinion recommending the revocation of the European Union marketing authorization","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CHMP","BK7501","BK4086","LU1169589451.USD","CSL.AU","LU1169590202.USD","SG9999004303.SGD","SGXZ23171101.USD","BK4087","LU0728928796.USD","BK7508","CSL","EEA","EPV","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647534917","title":"To Provide Details on Tavneos Ip Impairment in 2026 Full Year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2647534917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647534917?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","CSL.AU","BK7501","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647494883","title":"Expects FY26 Tavneos Sales Revenue of About $145 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2647494883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647494883?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7067","BK7508","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349179","title":"To Cease New Patient Initiation for Tavneos in EU and Eea Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349179","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349179?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7511","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647349176","title":"Ema Chmp Recommends Revocation of EU Marketing Authorisation for Tavneos on Jun 26","url":"https://stock-news.laohu8.com/highlight/detail?id=2647349176","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647349176?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:31","pubTimestamp":1782689483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y121:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","CSL.AU","BK7511","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647343252","title":"Commonwealth Bank Stock And 2 ASX Dividend Shares Paying More Than 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647343252","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647343252?lang=en_us&edition=fundamental","pubTime":"2026-06-29 01:14","pubTimestamp":1782666848,"startTime":"0","endTime":"0","summary":"Dividend Powerhouses are attracting fresh attention as investors weigh mixed signals across global markets, from shifting inflation expectations in the US and Europe to changing rate paths in Mexico, Brazil, and Japan. With bond yields moving and growth data sending a patchwork of signals, many income focused investors are looking at companies that pay more than a 5% dividend yield that is well covered, growing, and stable. This article highlights three stocks from the Dividend Powerhouses...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-asx-dividend-shares-paying-mor","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-asx-dividend-shares-paying-mor","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IAUM","SHNY","XKO.AU","BAR","XME","GOAU","DGP","IAU","GDXY","USG","GDX","AIPO","SGDM","CBA.AU","EVN.AU","JNUG","OUNZ","XAO.AU","GDXJ","KGLD","RING","JDST","AAAU","PHYS","GDXD","AGIX","CHAT","DBC","DULL","BTGD","GOLY","DZZ","ARTY","XJO.AU","UYM","GLL","GBUG","PICK","GLDM","IAUI","CSL.AU","GDXU","CEF","GLTR","VIG","BEGS","SGOL","FGDL","UGL","DUST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646508653","title":"Chmp Recommends Revoking Marketing Authorisation for Tavneos® (avacopan) in the European Union","url":"https://stock-news.laohu8.com/highlight/detail?id=2646508653","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646508653?lang=en_us&edition=fundamental","pubTime":"2026-06-26 21:00","pubTimestamp":1782478802,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nTUA8Y3PLC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CSL.AU","BK7508","BK7511","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646305359","title":"EU Commission Opens Antitrust Probe into Sanofi's Flu Vaccine Campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2646305359","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646305359?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:34","pubTimestamp":1782470088,"startTime":"0","endTime":"0","summary":"UPDATE 1-EU Commission opens antitrust probe into Sanofi's flu vaccine campaignAdds Sanofi reaction in paragraphs 4-5BRUSSELS, June 26 (Reuters)-The European Commission opened an investigation on Frid","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL8N42Y0LC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","BK7067","CSL.AU","BK7511","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646561793","title":"Sanofi Spokesperson on EU Probe: Cooperating Fully with the European Commission Throughout the Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2646561793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646561793?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:18","pubTimestamp":1782469123,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nB5N41C02P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7511","BK7067","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646178356","title":"Sanofi Spokesperson on EU Probe: Sanofi is Confident That it Has Acted, and Continues to Act, in Full Compliance with All Applicable Laws and Regulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2646178356","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646178356?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:18","pubTimestamp":1782469123,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nB5N41C02P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CSL.AU","BK7501","BK7508","BK7511","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646455333","title":"Commonwealth Bank Stock And 2 Australian Dividend Shares For Steady Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2646455333","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646455333?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:15","pubTimestamp":1782440138,"startTime":"0","endTime":"0","summary":"With inflation, interest rates and central bank moves pulling markets in different directions, many investors are looking for income that feels more dependable than short term price swings. That is where Dividend Powerhouses with a 5%+ yield, solid coverage and a track record of stable, growing payouts can help anchor a portfolio. This article looks at the Dividend Powerhouses (3%+ Yield) screener and highlights three of the stronger stocks it identifies, illustrating how consistently funded...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/commonwealth-bank-stock-and-2-australian-dividend-shares-for","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SLF.AU","VIG","XKO.AU","VAP.AU","IIGF.AU","ZYAU.AU","OZR.AU","IOZ.AU","GEAR.AU","BK4585","STW.AU","XAO.AU","BK7506","VAS.AU","XJO.AU","BK7501","CBA.AU","BEAR.AU","BK7104","E200.AU","CSL.AU","BK7511","QFN.AU","BK7508","NST.AU","AGIX","BK7135","AIPO","IMLC.AU","BBOZ.AU","BK7067","ARTY","BK4588","OZF.AU","GIVE.AU","CHAT","DACE.AU","EIGA.AU","IISV.AU","QRE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}